OIA
ARCT icon

Optimum Investment Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Optimum Investment Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22
Closed -$1K – 907
2021
Q1 		$1K Sell
22
-300
-93% -$17.9K ﹤0.01% 882
2020
Q4 		$14K Buy
322
+300
+1,364% +$20.3K ﹤0.01% 674
2020
Q3 		$1K Buy
+22
New +$1.09K ﹤0.01% 838

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Optimum Investment Advisors's ARCT Position: Q2 2021 in Review

Optimum Investment Advisors sold out of Arcturus Therapeutics (ARCT) in Q2 2021, closing a stake of 22 shares — an estimated $1K sold.

Optimum Investment Advisors first reported a position in ARCT in Q3 2020 and held it in 3 quarters. The position peaked at $14K in Q4 2020. 139 funds tracked by Wall St. Rank hold ARCT as of Q2 2021.

  • Optimum Investment Advisors reported no remaining Arcturus Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Optimum Investment Advisors sold 22 Arcturus Therapeutics shares in Q2 2021, an estimated $1K.
  • Optimum Investment Advisors first reported a position in Arcturus Therapeutics in Q3 2020 and held it in 3 quarters.
  • Optimum Investment Advisors's Arcturus Therapeutics position peaked at $14K in Q4 2020.
  • 139 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2021.

Based on Optimum Investment Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.